DNASE1L3 and autoimmune disease: They also provide further support for the hypothesis that reduced DNASE1L3 activity is a primary driver of the cfDNA abnormalities and disease phenotype in autoimmune disorders and, indeed, that its absence may provide the antigenic trigger responsible for the loss of tolerance to self-DNA observed in these disorders.